Activists in Ukraine hold critical roundtable on patent barriers on medicines

On April 15, 2015, the All-Ukrainian Network of People Living with HIV and AIDS convened a roundtable meeting titled Patent Barriers on Medicines: Potential Opportunities to Overcome the Barriers. The meeting brought together representatives of Indian and Ukrainian generic manufacturers in order to identify opportunities to overcome patent barriers through the use of compulsory licensing, […]

Thousands of activists urge company to change its policies on eve of shareholder meeting

New York, May 5, 2015 — On the eve of pharmaceutical company Gilead Sciences’ annual shareholder meeting, thousands of people who have hepatitis C virus (HCV) and HCV/HIV coinfection, with their allies and physicians, have demanded that Gilead change its policies that deny access to treatment for millions of people in developing countries. “Gilead must […]

Civil Society Opposes Patent Application on HIV Drug Truvada® In a Bid to Stop Argentina From Paying 30 Times More Than Other Countries

The International Treatment Preparedness Coalition (ITPC) supports the patent pre-grant opposition that was filed on 13 April 2015 by the Fundación Grupo Efecto Positivo (FGEP) and the Argentinian Network of Positive People (Redar Positive). The patent was filed at Argentina’s patent office and challenges the validity of a patent application submitted by Gilead Sciences on […]

ACT Toolkit

ACT Toolkit launches in English, French, Russian and Spanish

On Human Rights Day, the International Treatment Preparedness Coalition (ITPC) is proud to announce that our Advocacy for Community Treatment (ACT) Toolkit  is now available in English, French, Spanish and Russian. The ACT Toolkit facilitates community activists to become effective advocates for HIV treatment access. It includes a special focus on supporting key populations and ensuring everyone’s right to health is respected.

A Step Back for Millions of People with Hepatitis C

FOR IMMEDIATE RELEASE SEPTEMBER 19, 2014 A Step Back for Millions of People with Hepatitis C: Why Gilead’s Recent Deal with Generic Producers for its Hepatitis C Drugs (Sofosbuvir and Ledipasvir) is a Sham Hepatitis C Virus (HCV) Treatment: Gilead Sciences Voluntary License Under the pretext of increasing access to its hepatitis C treatment, the […]

IMG_2572

ITPC and ARASA Host Advocacy Workshop on Global Fund Resources and Sustainable Funding for HIV & TB in Botswana, Malawi and Tanzania

On 9-13 March 2015, ITPC, in collaboration with the Aids and Rights Alliance for Southern Africa (ARASA), facilitated an HIV and TB financing activist workshop aimed at strengthening key population advocacy for the best use of Global Fund resources and sustainable funding for HIV & TB in Botswana, Malawi and Tanzania. The meeting brought together […]

IMG_5318

ITPC and Partners Meet to Launch New Project on Access to HIV treatment in Middle-income Countries

The project, which is supported by UNITAID, will take place over the next three years and aims to remove patent barriers to generic competition in Argentina, Brazil, Ukraine and Thailand by reforming patent laws, challenging undeserved patents and advocating for the selective use of compulsory licenses. The three-day meeting was held at the Merlin Hotel […]

itpc-gileadskull1

Take Action

Sign ITPC’s petition to Gilead A recent decision by India’s Patent Office rejecting one of Gilead’s key patents for sofosbuvir is an important step for treatment activists. But Gilead is using every trick in the book to get the decision reversed, including lobbying the Indian Government. Sign our petition today to expand Hep C treatment!

act

ITPC and ARASA host workshop on Intellectual Property and Free Trade Agreements for activists in Johannesburg

News summary On November 24-28, 2014, the International Treatment Preparedness Coalition (ITPC) and the AIDS and Rights Alliance for Southern Africa (ARASA) held a joint workshop training, titled Community Involvement in Access to Affordable HIV Treatment: Focus on the Influence of Intellectual Property & Free Trade Agreements, at the Aviator Hotel in Johannesburg, South Africa. […]

ITPC and KeNPUD: Working together to protect the health and rights of PUDs in Kenya

In 2013, the International Treatment Preparedness Coalition (ITPC), through Bridging the Gaps, supported KeNPUD with a small grant to grow their organization. Mid-way through their ITPC grant, KeNPUD has conducted 15 advocacy actions, conseled 85 people, and held HIV education workshops for over 200 people. They continue to do health outreach to mobilize people to […]